Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease
Genetic Epidemiology · 2026
DOI: 10.1002/gepi.70045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetic Epidemiology, 2026. Verfasst von Jin Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Parkinson's disease (PD) is a complex neurodegenerative disorder with a significant genetic component. While genome‐wide association studies (GWAS) have been instrumental in identifying genetic variants associated with PD, the reliance on large sample sizes and population‐level analyses may overlook variants with lower minor allele frequencies or individual‐specific relevance. Individualized Bayesian Inference (IBI) offers a promising method to complement GWAS by identifying and prioritizing candidate genetic markers at both the individual and patients‐like‐me subgroup levels. This study evaluates the application of IBI to PD genetics, using GWAS as a baseline for comparison. We analyzed genetic data from the Fox Insight online study, including 8840 individuals (8585 PD cases and 255 controls). IBI prioritized variants that were not detected or were ranked substantially lower by GWAS, including variants within or near genes with prior PD association. The top 200 IBI SNPs showed stronger predictive performance in ANN models (AUC = 0.79) than the top 200 GWAS SNPs (AUC = 0.72), providing complementary support for the utility of IBI‐based prioritization in this cohort. Notably, IBI highlighted variants with lower minor allele frequencies that GWAS did not detect. This study demonstrates the utility of IBI as a complementary tool for prioritizing PD‐related candidate variants and genes for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology, University of Florida, Gainesville, Florida, USA.
- Department of Engineering Management and Systems Engineering, Missouri University of Science and Technology, Rolla, Missouri, USA.
- Department of Biostatistics, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Jinling Liu
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Ren, J., Soofi, Y. J., Rahman, M. A., Lu, Q., & Liu, J. (2026). Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease. Genetic Epidemiology. https://doi.org/10.1002/gepi.70045
Vancouver
Ren J, Soofi YJ, Rahman MA, Lu Q, Liu J. Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease. Genetic Epidemiology. 2026. doi:10.1002/gepi.70045
BibTeX
@article{Ren2026,
author = {Ren, Jin and Soofi, Yasaman J and Rahman, Md Asad and Lu, Qing and Liu, Jinling},
title = {Individualized Bayesian Inference Identifies Novel Genetic Variants for Parkinson's Disease},
journal = {Genetic Epidemiology},
year = {2026},
doi = {10.1002/gepi.70045}
}
EUVIMED